Vyzulta
Chemical Name | latanoprostene bunod ophthalmic solution |
Dosage Form | Solution (topical ophthalmic; 0.24 mg/mL (0.024%)) |
Drug Class | Ophthalmic agents |
System | Ocular |
Company | Bausch & Lomb |
Approval Year | 2017 |
Indication
- Vyzulta is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.